SCHEMBL22012072

SCHEMBL22012072

CC1CN(C(=O)c2ccc(N)c(F)c2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
PDK2 Q15119 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
GAA P10253 1/20 0.45
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 1/20 0.44
HSD11B1 P28845 3/20 0.43
CPS1 P31327 1/20 0.43
HPGD P15428 2/20 0.43
TP53 P04637 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17849533 0.82 LRRK2 (0.56) PDK2KMT2APLA2G1BATG4BGAA
SCHEMBL6838922 0.80 PLA2G7 (0.57) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL21962176 0.80 SMN1; SMN2 (0.55) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL355576 0.80 HPGD (0.56) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL15651449 0.79 HSD11B1 (0.48) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL21938853 0.79 HSD11B1 (0.50) PLA2G1BATG4BALDH1A1HSD11B1CPS1
SCHEMBL15651448 0.79 HSD11B1 (0.48) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL16982524 0.79 KMT2A (0.75) HDAC1HDAC6KMT2AMEN1HPGD
SCHEMBL13451259 0.78 HSD11B1 (0.52) HDAC1HDAC6KMT2AMEN1ALDH1A1
SCHEMBL22650841 0.77 L3MBTL3 (0.56) PDK2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed